NCT00537537View on ClinicalTrials.gov

To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

June 30, 2011

Conditions
Hepatitis B, Chronic
Interventions
DRUG

Telbivudine

Trial Locations (3)

Unknown

Novartis Investigative Site, Hyderabad

Novartis Investigative Site, Mumbai

Novartis Investigative Site, Vellore

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY